- Home
- AUPH vs INTR Comparison
AUPH vs INTR Comparison
Compare AUPH & INTR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | AUPH | INTR |
|---|---|---|
| Founded | 1993 | 1994 |
| Country | Canada | Brazil |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | |
| Sector | Health Care | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.1B | 2.3B |
| IPO Year | 2014 | 2021 |
Fundamental Metrics
Financial Performance| Metric | AUPH | INTR |
|---|---|---|
| Price | $14.93 | $5.62 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 4 | 2 |
| Target Price | ★ $17.25 | $10.00 |
| AVG Volume (30 Days) | 1.2M | ★ 4.2M |
| Earning Date | 05-07-2026 | 05-11-2026 |
| Dividend Yield | N/A | ★ 1.51% |
| EPS Growth | ★ 5075.00 | N/A |
| EPS | ★ 0.25 | N/A |
| Revenue | ★ $283,055,000.00 | N/A |
| Revenue This Year | $17.54 | $84.07 |
| Revenue Next Year | $15.74 | $18.26 |
| P/E Ratio | $60.02 | ★ $16.39 |
| Revenue Growth | ★ 20.38 | N/A |
| 52 Week Low | $10.34 | $5.16 |
| 52 Week High | $19.25 | $10.36 |
Technical Indicators
Market Signals| Indicator | AUPH | INTR |
|---|---|---|
| Relative Strength Index (RSI) | 37.04 | 49.01 |
| Support Level | $14.60 | $5.22 |
| Resistance Level | $15.23 | $6.02 |
| Average True Range (ATR) | 0.49 | 0.20 |
| MACD | -0.10 | 0.02 |
| Stochastic Oscillator | 17.08 | 58.49 |
Price Performance
Historical ComparisonAbout AUPH Aurinia Pharmaceuticals Inc
Aurinia Pharmaceuticals Inc is a biopharmaceutical company focused on delivering therapies to people living with autoimmune diseases with high unmet medical needs. The company developed LUPKYNIS (voclosporin), the first FDA-approved oral therapy for the treatment of adult patients with active lupus nephritis. It is also developing aritinercept, a dual inhibitor of B cell activating factor (BAFF) and a proliferation-inducing ligand (APRIL), for the potential treatment of autoimmune diseases.
About INTR Inter & Co. Inc.
Inter & Co Inc operates as a digital bank. The company's segment includes Banking & Spending; Investments; Insurance Brokerage; and Inter Shop. It generates maximum revenue from the Banking & Spending segment which comprises a wide range of banking products and services, such as checking accounts, cards, deposits, loans and advances, and other services, which are available to the clients by means of Inters mobile application.